Postprandial Hyperglycemia/Hyperlipidemia (Postprandial Dysmetabolism) Is a Cardiovascular Risk Factor

American Journal of Cardiology

Volumn 100, Issue 5, 2007, Pages 899-904

  O'Keefe, James H ^a,b   Bell, David S H ^c  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ACARBOSE; C REACTIVE PROTEIN; FREE RADICAL; GLIBENCLAMIDE; GLUCOSE; INCRETIN; INSULIN; METFORMIN; REPAGLINIDE;

ARTERY DIAMETER; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CORONARY RISK; DIET; DIET THERAPY; ENDOTHELIAL DYSFUNCTION; EXERCISE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERCOAGULABILITY; HYPERGLYCEMIA; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; OXIDATIVE STRESS; POSTPRANDIAL STATE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SYMPATHETIC TONE;

ANTILIPEMIC AGENTS; ATHEROSCLEROSIS; BLOOD GLUCOSE; CORONARY DISEASE; DIET; EXERCISE; FREE RADICALS; HUMANS; HYPERGLYCEMIA; HYPERLIPIDEMIAS; HYPOGLYCEMIC AGENTS; LIPIDS; OXIDATIVE STRESS; POSTPRANDIAL PERIOD; PROGNOSIS; RISK FACTORS;

EID: 34547957993     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.03.107     Document Type: Review

References (52)

1. Ceriello A., Assaloni R., Da Ros R., Maier A., Ludovica P., Quagliaro L., Esposity K., and Giugliano D. Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients. Circulation 111 (2005) 2518-2524
2. Bonora E., Corrao G., Bagnardi V., Ceriello A., Comaschi M., Montanari P., and Meigs J.B. Prevalence and correlates of post-prandial hyperglycaemia in a large sample of patients with type 2 diabetes mellitus. Diabetologia 49 (2006) 846-854
3. Weissman A., Lowenstein L., Peleg A., Thaler I., and Zimmer E.Z. Power spectral analysis of heart rate variability during the 100-g oral glucose tolerance test in pregnant women. Diabetes Care 29 (2006) 571-574
4. Conaway D.G., O'Keefe J.H., Reid K.J., and Spertus J. Frequency of undiagnosed diabetes mellitus in patients with acute coronary syndrome. Am J Cardiol 96 (2005) 363-365
5. Leiter L.A., Ceriello A., Davidson J.A., Hanefeld M., Monnier L., Owens D.R., Tajima N., Tuomilehto J., and International Prandial Glucose Regulation (PGR) Study Group. Postprandial glucose regulation: new data and new implications. Clin Ther 27 suppl (2005) S42-S56
6. Monnier L., and Colette C. Contributions of fasting and postprandial glucose to hemoglobin A1c. Endocr Pract 12 suppl (2006) 42-46
7. Cavalot F., Petrelli A., Traversa M., Bonoma K., Fiora E., Conti M., Anfossi G., Costa G., and Trovati M. Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus. J Clin Endocrinol Metab 91 (2006) 813-819
8. Ceriello A., Hanefeld M., Leiter L., Monnier L., Moses A., Owens D., Tajima N., and Tuomilehto J. Postprandial glucose regulation and diabetic complications. Arch Intern Med 164 (2004) 2090-2095
9. Tominaga M., Eguchi H., Manaka H., Igarashi K., Kato T., and Sekikawa A. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care 22 (1999) 920-924
10. Miyazaki M., Kubo M., Kiyohara Y., Okubo K., Makamura H., Fujisawa K., Hata Y., Tokunaga S., Iida M., Nose Y., and Ishibashi T. Comparison of diagnostic methods for diabetes mellitus based on presence of retinopathy in a Japanese population: the Hisayama Study. Diabetologia 47 (2004) 1411-1415
11. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352 (1998) 854-865
12. DECODE Study Group. Is the current definition of diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?. Diabetes Care 26 (2003) 688-696
13. Sasso F.C., Carbonara O., Nasti R., Campana B., Marfella R., Torella M., Nappi G., Torella R., and Cozzolino D. Glucose metabolism and coronary heart disease in patients with normal glucose tolerance. JAMA 291 (2004) 1857-1863
14. Mellen P.B., Cefalu W.T., and Herrington D.M. Diabetes, the metabolic syndrome, and angiographic progression of coronary arterial disease in postmenopausal women. Arterioscler Thromb Vasc Biol 26 (2006) 189-193
15. Anderson R.A., Evans M.L., Ellis G.R., Graham J., Morris K., Jackson S.K., Lewis M.J., Rees A., and Frenneaux M.P. The relationships between post-prandial lipaemia, endothelial function and oxidative stress in healthy individuals and patients with type 2 diabetes. Atherosclerosis 154 (2001) 475-483
16. Eberly L.E., Stamler J., and Neaton J.D. Relation of triglyceride levels, fasting and nonfasting, to fatal and nonfatal coronary heart disease. Arch Intern Med 163 (2003) 1077-1083
17. Gaziano J.M., Hennekens C.H., O'Donnell C.J., Breslow J.L., and Buring J.E. Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation 96 (1997) 2520-2525
18. Teno S., Uto Y., Nagashima H., Endoh Y., Iwamoto Y., Omori Y., and Takizawa T. Association of postprandial hypertriglyceridemia and carotid intima-media thickness in patients with type 2 diabetes. Diabetes Care 23 (2000) 1401-1406
19. Ceriello A., and Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease?. Arterioscler Thromb Vasc Biol 24 (2004) 816-823
20. Ferreira A.C., Peter A.A., Mendez A.J., Jimenez J.J., Mauro L.M., Chirinos J.A., Ghany R., Virani S., Garcia S., Horstman L.L., et al. Postprandial hypertriglyceridemia increases circulating levels of endothelial cell microparticles. Circulation 110 (2004) 3599-3603
21. Ceriello A., Quagliaro L., Piconi L., Assaloni R., Da Ros R., Maier A., Esposito K., and Giugliano D. Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment. Diabetes 53 (2004) 701-710
22. Monnier L., Mas E., Ginet C., Michel F., Villon L., Cristol J.P., and Colette C. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295 (2006) 1681-1687
23. Brownlee M., and Hirsch I.B. Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications. JAMA 295 (2006) 1707-1708
24. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414 (2001) 813-820
25. Schulze M.B., Liu S., Rimm E.B., Manson J.E., Willett W.C., and Hu F.B. Glycemic index, glycemic load, and dietary fiber intake and incidence of type 2 diabetes in younger and middle-aged women. Am J Clin Nutr 80 (2004) 348-356
26. Brand-Miller J.C. Postprandial glycemia, glycemic index, and the prevention of type 2 diabetes. Am J Clin Nutr 80 (2004) 243-244
27. O'Keefe Jr. J.H., and Cordain L. Cardiovascular disease resulting from a diet and lifestyle at odds with our Paleolithic genome: how to become a 21st-century hunter-gatherer. Mayo Clin Proc 79 (2004) 101-108
28. Cordain L., Eaton S.B., Sebastian A., O'Keefe J.H., and Brand-Miller J. Origins and evolution of the Western diet: health implications for the 21st century. Am J Clin Nutr 81 (2005) 341-354
29. Roberts C.K., Won D., Pruthi S., Kurtovic S., Sindhu R.K., Vaziri N.D., and Barnard R.J. Effect of a short-term diet and exercise intervention on oxidative stress, inflammation, MMP-9, and monocyte chemotactic activity in men with metabolic syndrome factors. J Appl Physiol 100 (2006) 1657-1665
30. Greenfield J.R., Samaras K., Hayward C.S., Chisholm D.J., and Campbell L.V. Beneficial postprandial effect of a small amount of alcohol on diabetes and cardiovascular risk factors: modification by insulin resistance. J Clin Endrocrinol Metab 90 (2005) 661-672
31. Mukamal K.J., Conigrave K.M., Mittleman M.A., Camargo Jr. C.A., Stampfer M.J., Willett W.C., and Rimm E.B. Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med 348 (2003) 109-118
32. Koppes L.L., Dekker J.M., Hendriks H.F., Bouter L.M., and Heine R.J. Moderate alcohol consumption lowers the risk of type 2 diabetes. Diabetes Care 28 (2005) 719-725
33. Johnston C.S., and Buller A.J. Vinegar and peanut products as complementary foods to reduce postprandial glycemia. J Am Diet Assoc 105 (2005) 1939-1942
34. Nilsson M., Holst J.J., and Björek I.M.E. Metabolic effects of amino acid mixtures and whey protein in healthy subjects: studies using glucose-equivalent drinks. Am J Clin Nutr 85 (2007) 996-1004
35. Kris-Etherton P.M., Harris W.S., and Appel L.J. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106 (2002) 2747-2757
36. Tansey M.J., Tsalikian E., Beck R.W., Mauras N., Buckingham B.A., Weinzimer S.A., Janz K.F., Kollman C., Xing D., Ruedy K.J., et al., The Diabetes Research in Children Network Study Group. The effects of aerobic exercise on glucose and counterregulatory hormone concentrations in children with type 1 diabetes. Diabetes Care 29 (2006) 20-25
37. O'Keefe J.H., Captain B.K., Jones P.G., and Harris W.S. Atorvastatin reduces remnant lipoproteins and small dense LDL regardless of baseline lipid pattern. Prev Cardiol 7 (2004) 154-160
38. Shimabukuro M., Higa N., Chinen I., Yamakawa K., and Takasu N. Effects of a single administration of acarbose on postprandial glucose excursion and endothelial dysfunction in type 2 diabetic patients: a randomized crossover study. J Clin Endocrinol Metab 91 (2006) 837-842
39. Ogawa S., Takeuchi K., and Ito S. Acarbose lowers serum triglyceride and postprandial chylomicron levels in type 2 diabetes. Diabetes Obes Metab 6 (2004) 384-390
40. Chiasson J.L., Josse R.G., Gomis R., Hanefeld M., Karasik A., Laakso M., and STOP-NIDDM Trial Research Group. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance. JAMA 290 (2003) 486-494
41. Hanefeld M., Cagatay M., Petrowitsch T., Neuser D., Petzinna D., and Rupp M. Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies. Eur Heart J 25 (2004) 10-16
42. Weissman P., Goldstein B.J., Rosenstock J., Waterhouse B., Cobitz A.R., Wooddell M.J., and Strow L.J. Effects of rosiglitazone added to submaximal doses of metformin compared with dose escalation of metformin in type 2 diabetes: the EMPIRE study. Curr Med Res Opin 21 (2005) 2029-2035
43. Shimabukuro M., Higa N., Takasu N., Tagawa T., and Ueda S. A single dose of nateglinide improves post-challenge glucose metabolism and endothelial dysfunction in type 2 diabetes. Diabet Med 21 (2004) 983-986
44. Esposito K., Giugliano D., Nappo F., and Marfella R. Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes. Circulation 110 (2004) 214-219
45. Ceriello A., Cavarape A., Martinelli L., Da Ros R., Marra G., Quagliaro L., Piconi L., Assaloni R., and Motz E. The post-prandial state in type 2 diabetes and endothelial dysfunction: effects of insulin aspart. Diabet Med 21 (2004) 171-175
46. Riddle M.C., and Drucker D.J. Emerging therapies mimicking the effects of amylin and glucagon-like peptide 1. Diabetes Care 29 (2006) 435-449
47. Rosenstock J., Baron M.A., Dejager S., Mills D., and Schweizer A. Comparison of vildagliptin and rosiglitazone monotherapy in patients with type 2 diabetes: a 24-week, double-blind, randomized trial. Diabetes Care 30 (2007) 217-223
48. Matikainen N., Mänttäri S., Schweizer A., Ulvestad A., Mills D., Dunning B.E., Foley J.E., and Taskinen M.R. Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes. Diabetologia 49 (2006) 2049-2057
49. Lebovitz H.E., Austin M.M., Blonde L., Davidson J.A., Del Prato S., Gavin III J.R., Handelsman Y., Jellinger P.S., Levy P., Riddle M.C., et al., ACE/AACE Diabetes Recommendations Implementation Writing Committee. ACE/AACE consensus conference on the implementation of outpatient management of diabetes mellitus: consensus conference recommendations. Endocr Pract 12 (2006) 6-12
50. Brohall G., Behre C.-J., Hulthe J., Wikstrand J., and Fagerberg B. Prevalence of diabetes and IGT in 64-year old Swedish women, experiences of using repeated oral glucose tolerance tests. Diabetes Care 29 (2006) 363-367
51. Saudek C.D., Derr R.L., and Kalyani R.R. Assessing glycemia in diabetes using self-monitoring blood glucose and HbA1c. JAMA 295 (2006) 1688-1697
52. Miller M., Zhan M., and Georgopoulos A. Effect of desirable fasting triglycerides on the postprandial response to dietary fat. J Investig Med 51 (2003) 50-55